ROBERT F WAGNER
Pharmacy in Millstone, NJ
License number
New Jersey 28RI01705200
Issued Date
Jan 7, 1982
Expiration Date
Apr 30, 2017
Category
Pharmacy
Type
Pharmacist
Address
Address
Millstone, NJ
Personal information
See more information about ROBERT F WAGNER at radaris.comName
Address
Phone
512 Prospect Ave, Ridgefield, NJ 07657
52 Sturbridge Dr, Sicklerville, NJ 08081
522 Broad Ave, Mantoloking, NJ 08738
523 Arch St, Delran, NJ 08075
Professional information
Pharmaceutical Formulation Of Valsartan
US Patent:
2013010, Apr 25, 2013
Filed:
Oct 17, 2012
Appl. No.:
13/653738
Inventors:
Novartis AG - Basel, CH
Robert Frank Wagner - Hillsborough NJ, US
Hong Wen - Westfield NJ, US
Robert Frank Wagner - Hillsborough NJ, US
Hong Wen - Westfield NJ, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 31/41, A61K 31/546, A61K 45/06
US Classification:
5142225, 514381
Abstract:
The present invention relates to a pharmaceutical composition in a form of suspension for oral administration comprising valsartan or its pharmaceutically acceptable salts and at least one or two or more of the components selected from glycerol or syrup or the mixture thereof, a preservative, a buffer system and a suspending/stabilizing agent. The present invention further relates to the therapeutic uses of the pharmaceutical composition.
Solid Dosage Forms Of Valsartan, Amlodipine And Hydrochlorothiazide And Method Of Making The Same
US Patent:
2010000, Jan 7, 2010
Filed:
Jun 26, 2007
Appl. No.:
11/915096
Inventors:
Yu Cao - Parsippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E. Royce - Saylorsburg PA, US
Robert F. Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E. Royce - Saylorsburg PA, US
Robert F. Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
International Classification:
A61K 31/549, A61K 9/20, A61P 9/00, A61P 25/00
US Classification:
424474, 5142235, 424464
Abstract:
Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
Tablet Formulations Comprising Valsartan
US Patent:
2003015, Aug 14, 2003
Filed:
Feb 25, 2003
Appl. No.:
10/374801
Inventors:
Sabina Ganter - Rheinhausen, DE
Robert Wagner - Hillsborough NJ, US
Robert Wagner - Hillsborough NJ, US
International Classification:
A61K031/41, A61K009/48
US Classification:
424/452000, 514/381000
Abstract:
The invention relates to solid oral dosage forms comprising pharmacologically effective amounts of valsartan or a pharmaceutically acceptable salt thereof or hydrate thereof. The compositions are at least 1.2 times more bioavailable than conventional valsartan capsule.
Solid Dosage Forms Of Valsartan, Amlodipine And Hydrochlorothiazide And Method Of Making The Same
US Patent:
8435563, May 7, 2013
Filed:
Jan 3, 2012
Appl. No.:
13/342533
Inventors:
Yu Cao - Parsippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E Royce - Saylorsburg PA, US
Robert F Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E Royce - Saylorsburg PA, US
Robert F Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
Assignee:
Novartis Pharmaceuticals Corporation - East Hanover NJ
International Classification:
A61K 31/549, A61K 9/28, A61P 9/12, A61P 9/04, A61P 9/10, A61P 9/00
US Classification:
424464, 427 214, 5142232, 5142235, 514355, 514381
Abstract:
Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
Valsartan Solid Oral Dosage Forms And Methods Of Making Such Formulations
US Patent:
2011002, Feb 3, 2011
Filed:
Feb 27, 2009
Appl. No.:
12/919165
Inventors:
Amol Matharu - Bedminster NJ, US
Agnes Taillardat - Seewen So, CH
Robert F. Wagner - Hillsborough NJ, US
Agnes Taillardat - Seewen So, CH
Robert F. Wagner - Hillsborough NJ, US
International Classification:
A61K 31/41, A61P 9/04
US Classification:
514381
Abstract:
The invention relates to melt granulation processes for preparing immediate release and sustained release pharmaceutical formulations comprising valsartan.
Microemulsion Dosage Forms Of Valsartan And Methods Of Making The Same
US Patent:
2010003, Feb 11, 2010
Filed:
Dec 3, 2007
Appl. No.:
12/517105
Inventors:
Yatindra Joshi - Princeton NJ, US
John J. Kennedy - Hillsborough NJ, US
Ping Li - Basking Ridge NJ, US
Alan E. Royce - Saylorsburg PA, US
Robert F. Wagner - Hillsborough NJ, US
John J. Kennedy - Hillsborough NJ, US
Ping Li - Basking Ridge NJ, US
Alan E. Royce - Saylorsburg PA, US
Robert F. Wagner - Hillsborough NJ, US
International Classification:
A61K 31/41, A61P 9/12, A61P 9/00
US Classification:
514381
Abstract:
A drug delivery system, e.g., microemulsion preconcentrate, that spontaneously forms a microemulsion when brought in contact with an aqueous medium. The drug delivery system contains valsartan, a hydrophilic component, a lipophilic component and a surfactant. A particularly useful hydrophilic component in the system is a polymer that is solid at room temperature, e.g., solid PEG.
Solid Dosage Forms Of Valsartan, Amlodipine And Hydrochlorothiazide And Method Of Making The Same
US Patent:
8475839, Jul 2, 2013
Filed:
Jan 3, 2012
Appl. No.:
13/342533
Inventors:
Yu Cao - Parsippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E Royce - Saylorsburg PA, US
Robert F Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
Yatindra Joshi - Princeton NJ, US
Ping Li - Basking Ridge NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Alan E Royce - Saylorsburg PA, US
Robert F Wagner - Hillsborough NJ, US
Jiahao Zhu - Whippany NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/549, A61K 9/28, A61P 9/12, A61P 9/04, A61P 9/10, A61P 9/00
US Classification:
424464, 427 214, 5142232, 5142235, 514355, 514381
Abstract:
Monolayer, bilayer and trilayer solid dosage forms of a combination of valsartan, amlodipine and hydrochlorothiazide are made.
Solid Dosage Forms Of Valsartan And Amlodipine And Method Of Making The Same
US Patent:
2012017, Jul 12, 2012
Filed:
Feb 23, 2012
Appl. No.:
13/403638
Inventors:
Yatindra Joshi - Princeton NJ, US
Robert Frank Wagner - Hillsborough NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Gangadhar Sunkara - Parsippany NJ, US
Ping Li - Basking Ridge NJ, US
Robert Frank Wagner - Hillsborough NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Gangadhar Sunkara - Parsippany NJ, US
Ping Li - Basking Ridge NJ, US
International Classification:
A61K 31/4422, A61P 9/04, A61P 25/00, A61P 9/00, A61P 13/12, A61K 9/20, A61P 9/10
US Classification:
424464, 514356
Abstract:
Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
Solid Dosage Forms Of Valsartan And Amlodipine And Method Of Making Same
US Patent:
2010030, Dec 2, 2010
Filed:
Aug 9, 2010
Appl. No.:
12/852542
Inventors:
Yatindra Joshi - Princeton NJ, US
Robert Frank Wagner - Hillsborough NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Gangadhar Sunkara - Parsippany NJ, US
Ping Li - Basking Ridge NJ, US
Robert Frank Wagner - Hillsborough NJ, US
Madhusudhan Pudipeddi - Mumbai, IN
Gangadhar Sunkara - Parsippany NJ, US
Ping Li - Basking Ridge NJ, US
International Classification:
A61K 9/24, A61K 31/44, B05D 3/12, A61P 9/12, A61P 9/00, A61P 9/10, A61P 25/00
US Classification:
424464, 514356, 427 214
Abstract:
Monolayer and bilayer solid dosage forms of a combination of valsartan and amlodipine are made.
Pharmaceutical Composition
US Patent:
2013010, May 2, 2013
Filed:
Dec 20, 2012
Appl. No.:
13/721521
Inventors:
Novartis AG - Basel, CH
Wayne Talamonti - Kunkletwon PA, US
Robert Frank Wagner - Hillsborough NJ, US
Joseph Lawrence Zielinski - Florham Park NJ, US
Wayne Talamonti - Kunkletwon PA, US
Robert Frank Wagner - Hillsborough NJ, US
Joseph Lawrence Zielinski - Florham Park NJ, US
Assignee:
Novartis AG - Basel
International Classification:
A61K 31/41
US Classification:
514381
Abstract:
Provided are compositions comprising aqueous solutions of valsartan suitable for oral administration, preferably in pediatric and geriatric populations. Methods for making such compositions and methods for their stabilization are provided.